BLS.AX · BLS PHARMACEUTICALS LIMITED
Australia · RS rating 95 · As of 2026-11-03
| Price | 0.94 AUD |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 95 / 62 / 83 / 97 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 37 / 40 / 47 |
| Industry group (rank) | Medical-Products (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +27.5% |
| Market cap (USD) | $169.8M |